Medtronic to acquire affera

Acquisition to expand company's cardiac ablation portfolio, including first-time entry into mapping and navigation, within one of the fastest growing medtech markets dublin, jan. 10, 2022 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, today announced that it has entered into a definitive agreement to acquire affera, inc., a boston area-based, privately held medical technology company. affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the treatment of patients with cardiac arrhythmias (irregular heartbeats) such as atrial fibrillation (af).
MDT Ratings Summary
MDT Quant Ranking